RELAPSED/REFRACTORY SMALL CELL LUNG CANCER
Clinical trials for RELAPSED/REFRACTORY SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat lung cancer: experimental combo enters human trials
Disease control Recruiting nowThis study tests an experimental drug called BMS-986525, given alone or with an immunotherapy drug (nivolumab), in about 240 people whose small cell lung cancer has returned or stopped responding to standard chemotherapy. The main goals are to check safety and side effects, and t…
Matched conditions: RELAPSED/REFRACTORY SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 26, 2026 08:23 UTC
-
Engineered immune cells take on tough lung cancer in first human trial
Disease control Recruiting nowThis early study tests a new treatment called GC511B for adults with small cell lung cancer that has come back or not responded to standard therapy. The treatment uses specially engineered immune cells (CAR T cells) to target a protein called DLL3 on cancer cells. The main goals …
Matched conditions: RELAPSED/REFRACTORY SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 20, 2026 11:56 UTC